Vertex Pharmaceuticals Inc / Ma
VRTXNasdaqCIK 875320HealthcareFiscal year ends Dec 31
Reports and events: 289 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2019-09-0312:49 ET | 8-K | 1.01 Entry into a material agreement | 0000875320-19-000043 |
| 2019-08-0120:20 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0000875320-19-000037 |
| 2019-07-3120:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-19-000031 |
| 2019-07-2520:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000875320-19-000026 |
| 2019-06-0720:23 ET | 8-K | 1.01 Entry into a material agreement | 0000875320-19-000023 |
| 2019-06-0716:04 ET | SC 13D/A | Ownership report, active investor, amended | 0001341004-19-000394 |
| 2019-06-0520:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000875320-19-000021 |
| 2019-05-0120:37 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0000875320-19-000019 |
| 2019-04-3020:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-19-000017 |
| 2019-04-2620:38 ET | DEF 14A | Proxy statementPeriod 2019-06-05 | 0001308179-19-000189 |
| 2019-04-0221:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000875320-19-000012 |
| 2019-02-2221:56 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000875320-19-000009 |
| 2019-02-1321:38 ET | 10-K | Annual reportPeriod 2018-12-31 | 0000875320-19-000006 |
| 2019-02-0521:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-19-000003 |
| 2019-01-2321:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001341004-19-000045 |
| 2018-12-2816:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001341004-18-000692 |
| 2018-12-2616:33 ET | SC 13D/A | Ownership report, active investor, amended | 0001341004-18-000685 |
| 2018-12-2117:14 ET | SC 13D | Ownership report, active investor | 0001341004-18-000680 |
| 2018-12-1713:19 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001341004-18-000674 |
| 2018-10-2520:10 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0000875320-18-000029 |
| 2018-10-2420:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-18-000026 |
| 2018-07-2620:08 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0000875320-18-000022 |
| 2018-07-2520:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-18-000019 |
| 2018-05-1820:07 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results | 0000875320-18-000016 |
| 2018-04-2720:36 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0000875320-18-000014 |
| 2018-04-2620:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-18-000011 |
| 2018-04-1720:02 ET | DEF 14A | Proxy statementPeriod 2018-04-17 | 0001308179-18-000188 |
| 2018-02-1523:01 ET | 10-K | Annual reportPeriod 2017-12-31 | 0000875320-18-000009 |
| 2018-02-1222:01 ET | 8-K | 7.01 Regulation FD disclosure | 0000875320-18-000005 |
| 2018-01-3121:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-18-000002 |
| 2017-10-3021:15 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0000875320-17-000060 |
| 2017-10-2720:03 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000875320-17-000057 |
| 2017-10-2520:09 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 2.06 Material impairments; 9.01 Financial statements and exhibits | 0000875320-17-000054 |
| 2017-09-0620:57 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000875320-17-000050 |
| 2017-07-2820:23 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0000875320-17-000047 |
| 2017-07-2620:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-17-000043 |
| 2017-06-0820:41 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results | 0000875320-17-000039 |
| 2017-05-2211:56 ET | 8-K | 8.01 Other events | 0000875320-17-000036 |
| 2017-04-2820:22 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0000875320-17-000030 |
| 2017-04-2813:03 ET | DEF 14A | Proxy statementPeriod 2017-04-28 | 0001308179-17-000169 |
| 2017-04-2720:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-17-000027 |
| 2017-03-2911:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000875320-17-000025 |
| 2017-03-0621:54 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000875320-17-000022 |
| 2017-02-2320:18 ET | 10-K | Annual reportPeriod 2016-12-31 | 0000875320-17-000017 |
| 2017-01-2521:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-17-000009 |
| 2017-01-1114:08 ET | 8-K | 1.01 Entry into a material agreement | 0000875320-17-000007 |
| 2017-01-0914:17 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-17-000005 |
| 2017-01-0912:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-17-000003 |
| 2016-12-0213:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000875320-16-000112 |
| 2016-10-3120:48 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0000875320-16-000107 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 12:56 ET. Listed shows no prices and gives no investment advice.